Oncotype DX genomic testing services for madigan army medical center, JBLM, WA.

Active Purchase Order Awarded Last action

Contract number
W81K0223P0100
Awardee
Awarding agency
Obligated
$283,176

Award facts

Opportunity
Contract value 53% obligated
  • $407,161.45 Current, with exercised options
  • $531,146.70 Potential, with all options
Completion date 61% complete
  • Current, with exercised options
  • Potential, with all options
Contracting staff
NAICS code
621511 Medical Laboratories
Set-aside
No set-aside
Competition
Not Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Redwood City, CA 94063, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Exercise an Option P00012 $0
Other Administrative Action P00011 · Cologuard test, oncoguard liver test, oncotype breast test, oncotype colon test, oncotype breast test, oncotype panels test, oncotype microdissection test $0
Other Administrative Action P00010 $0
Funding Only Action P00009 $123,985
Exercise an Option P00008 $0
Supplemental Agreement for work within scope P00007 · Oncotype DX lab testing mamc -$26,966
Supplemental Agreement for work within scope P00006 · Oncotype tests - deobligate FY24 funds -$61,814
Funding Only Action P00005 · Oncotype DX-breast test add FY25 funding $123,985
Supplemental Agreement for work within scope P00004 · Oncotype DX-dcis breast test - adjust clin quantities -$137
Exercise an Option P00003 · OY 1 FY25 oncotype DX-dcis breast test $0
Funding Only Action P00002 · FY24 funds release for oncotype DX genomic testing services for mamc, WA for 01 OCT 2023 - 30 SEP 2024. $124,122
Other Administrative Action P00001 · Oncotype DX genomic testing services for mamc, WA - administrative modification to identify clins 1001-1007, 2001-2007, 3001-3007, and 4001-4007 as option… $0
Original award $0
Show all 13

About this award

Written by GovTribe AI ·

The Defense Health Agency awarded a purchase order to Exact Sciences Corporation for Oncotype DX genomic testing services at Madigan Army Medical Center, Joint Base Lewis-McChord, Washington, with a ceiling value of $531,146.70, effective October 1, 2023. Work is performed at Exact Sciences Laboratories in Redwood City, California. The order covers Oncotype DX breast, colon, and prostate cancer genomic testing assays, Cologuard colorectal screening tests, and Oncoguard liver testing services on a firm fixed-price basis. The purchase order extends through September 30, 2028, and originated from a Defense Health Agency pre-solicitation notice posted April 17, 2023.

Quick answers

Who was awarded contract W81K0223P0100?

W81K0223P0100 was awarded to Exact Sciences Corporation by Defense Health Agency (Department of Defense) on October 1, 2023.

How much is contract W81K0223P0100 worth?

The government has obligated $283,176 on W81K0223P0100. Its current value, with exercised options, is $407,161. Its potential value, with all options, is $531,147.

Was contract W81K0223P0100 competed?

The extent of competition for W81K0223P0100 was not competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login